Multiple Myeloma Awareness Month: When the Doctor Becomes the Caregiver

Read More

Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer

Reddy SM., el at.
November 2020
Authors and Affiliates
Sangeetha M Reddy 1,2, Alexandre Reuben 3,4, Souptik Barua 5,6, Hong Jiang 3, Shaojun Zhang 7, Linghua Wang 7, Vancheswaran Gopalakrishnan 3, Courtney W Hudgens 8, Michael T Tetzlaff 8,9, James M Reuben 10,11, Takahiro Tsujikawa 12,13, Lisa M Coussens 12, Khalida Wani 8, Yan He 8, Lily Villareal 11, Anita Wood 11, Arvind Rao 6,14, Wendy A Woodward 11,15, Naoto T Ueno 16,11, Savitri Krishnamurthy 17,18, Jennifer A Wargo 19,7, Elizabeth A Mittendorf 20,21,22; 1 Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2 Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas. 3 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 4 Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 5 Department of Electrical and Computer Engineering, Rice University, Houston, Texas. 6 Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan. 7 Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. 8 Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 9 Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 10 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 11 Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, Texas. 12 Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, Oregon. 13 Department of Otolaryngology-Head and Neck Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan. 14 Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. 15 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 16 Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. emittendorf@bwh.harvard.edu jwargo@mdanderson.org skrishna@mdanderson.org nueno@mdanderson.org. 17 Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, Texas. emittendorf@bwh.harvard.edu jwargo@mdanderson.org skrishna@mdanderson.org nueno@mdanderson.org. 18 Department of Breast Surgical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 19 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. emittendorf@bwh.harvard.edu jwargo@mdanderson.org skrishna@mdanderson.org nueno@mdanderson.org. 20 Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. emittendorf@bwh.harvard.edu jwargo@mdanderson.org skrishna@mdanderson.org nueno@mdanderson.org. 21 Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts. 22 Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.